metics have come under scrutiny, as concerns have mounted over their potentially harmful effects on the pancreas. On March 14, the U.S. Food & Drug Administration (FDA) announced it was investigating findings from an unpublished study that suggested Byetta and other incretin mimetics could be associated with pre-cancerous cellular changes in the pancreas called pancreatic duct metaplasia.* The month prior, a paper published in JAMA Internal Medicine reported that drugs like Byetta appeared to double the risk for pancreatitis, a known risk factor for pancreatic cancer.** A year earlier, research published in Gastroenterology found that Byetta increased the risk of pancreatic cancer by nearly 3-fold. The same study also reported 30 cases of thyroid cancer in patients taking the drug, and a six-fold increase risk for pancreatitis among Byetta users.***
According to Bernstein Liebhard LLP, multidistrict litigations like that proposed for Byetta lawsuits are established when a large number of complex cases share common allegations of facts. The aim of such a proceeding is to preserve the resources of the Court, parties and witnesses, and to avoid duplicative discovery and conflicting orders.
Byetta users who developed pancreatic cancer, pancreatitis or thyroid cancer may be entitled to compensation for medical bills, lost wages, and pain and suffering. Additional information about filing a Byetta lawsuit is available at Bernstein Liebhard LLP’s website. To learn more, please call 800-511-5092.
*fda.gov/Drugs/DrugSafety/ucm343187.htm, FDA, March 14, 2013
**archinte.jamanetwork.com/article.aspx?articleid=1656537, JAMA Internal Medicine, February 25, 2013
***gastrojournal.org/article/S0016-5085%2811%2900172-7/abstract, Gastroenterology, February 21, 2011
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action
Page: 1 2 3 Related medicine news :1
Copyright©2012 Vocus, Inc.
All rights reserved
. d'Oliveira & Associates Releases New Byetta Infographic on Potential Kidney and Pancreas Health Risks Associated with the Drug2
. Byetta Pancreatic Cancer Allegation Lawsuits Offered through Resource4thePeople3
. DrugRisk Announces Launch of Byetta Cancer Resource Center4
. Pancreatic Cancer Correlation to Type 2 Diabetes Drugs Januvia and Byetta, New Studies Find Possible Connection5
. DrugRisk Update: New Study Warns of Cancer in Byetta Side Effects6
. Byetta Lawsuit News: Woman Alleges Her Thyroid Cancer Is Linked to Byetta Use, Rottenstein Law Group LLP Reports7
. DrugRisk Update: Byetta Maker Agrees With Transferring Lawsuits to Federal Court8
. Byetta Lawyers at Gilman Law, a Leading Pharmacy Law and Defective Drug Plaintiffs’ Law Firm, Troubled by Growing Byetta Pancreatic Cancer Reports9
. Diabetes Drug Byetta Caused Arkansas Man’s Pancreatic Cancer and Resulting Injuries, Alleges Lawsuit Filed by Parker Waichman LLP and Co-Counsel10
. Rottenstein Law Group LLP Comments on Drugmakers’ Cooperation With Safety Review of Byetta, Januvia, Victoza11
. Byetta Pancreatic Cancer Lawsuit News: Bernstein Liebhard LLP Comments on BMJ Investigation Finding Incretin Mimetic Risks Were Downplayed